Free Cash Flow
ProShares Ultra Nasdaq Biotechnolog... (BIB)
$51.76
+1.26 (+2.50%)
Free Cash Flow
Year A/P |
| Revenue |
|---|
| Revenue (%) |
| Operating Cash Flow |
| Operating Cash Flow (%) |
| Capital Expenditure |
| Capital Expenditure (%) |
| Free Cash Flow |
FCF Unlevered from cash flow statement